Cargando…
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort
The longer-term consequences of SARS-CoV-2 infection are uncertain. Consecutive patients hospitalised with COVID-19 were prospectively recruited to this observational study (n=163). At 8–12 weeks postadmission, survivors were invited to a systematic clinical follow-up. Of 131 participants, 110 atten...
Autores principales: | Arnold, David T, Hamilton, Fergus W, Milne, Alice, Morley, Anna J, Viner, Jason, Attwood, Marie, Noel, Alan, Gunning, Samuel, Hatrick, Jessica, Hamilton, Sassa, Elvers, Karen T, Hyams, Catherine, Bibby, Anna, Moran, Ed, Adamali, Huzaifa I, Dodd, James William, Maskell, Nicholas A, Barratt, Shaney L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716340/ https://www.ncbi.nlm.nih.gov/pubmed/33273026 http://dx.doi.org/10.1136/thoraxjnl-2020-216086 |
Ejemplares similares
-
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
por: Zulfikar, Sabrina, et al.
Publicado: (2020) -
Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks
por: Arnold, David T., et al.
Publicado: (2021) -
Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort
por: Tomlins, Jennifer, et al.
Publicado: (2020) -
Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services
por: Barratt, Shaney L, et al.
Publicado: (2021) -
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2
por: MacGowan, Alasdair, et al.
Publicado: (2021)